Health committee  I would just add that most Canadians have an expectation that when a drug is approved and sold on the market in Canada, it has been shown to be safe. That is the precautionary principle, that during clinical trials a drug is shown to be safe. The risk management approach is that

Health committee  When patients contact us, they tell us about the positive effects of.... Most of the patients we talk to are taking more than one drug. They have both positive and negative experiences; it's not only negative experiences. Yes, patients do have a role in communicating the effect

Health committee  We have enough information to have an idea about who is reporting amongst consumers. For example, both in Canada and internationally, it's known that women are more likely to report than men. They report on their own behalf and they report on behalf of family members and so on.

Health committee  We are a critical voice. We criticize Health Canada. We criticize the pharmaceutical industry for policies that result in harm. That's what our role is. We have been, and continue to be, critical of Health Canada because we feel that their orientation is focused on creating a fri

Health committee  No, we don't get any money from big or small pharma.

Health committee  From our perspective, the biggest problem with the vaccine is its promotion. This is a new vaccine. The clinical trial history could have been more complete and longer, from our perspective. But there is no clinical trial that will ever be able to detect all of the potential risk

Health committee  Okay. I'll finish by saying that the marketed health products directorate needs a greater investment in direct consumer reporting. Thank you.

Health committee  Thank you. I'm representing PharmaWatch. My name is Colleen Fuller, and my colleague Carol Kushner and I are both going to present. First of all, thank you very much for inviting PharmaWatch. We're really pleased that the standing committee is looking at post-market surveillan